2024
DOI: 10.1038/s41586-024-07148-y
|View full text |Cite
|
Sign up to set email alerts
|

Genome-wide characterization of circulating metabolic biomarkers

Minna K. Karjalainen,
Savita Karthikeyan,
Clare Oliver-Williams
et al.

Abstract: Genome-wide association analyses using high-throughput metabolomics platforms have led to novel insights into the biology of human metabolism1–7. This detailed knowledge of the genetic determinants of systemic metabolism has been pivotal for uncovering how genetic pathways influence biological mechanisms and complex diseases8–11. Here we present a genome-wide association study for 233 circulating metabolic traits quantified by nuclear magnetic resonance spectroscopy in up to 136,016 participants from 33 cohort… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
3

Relationship

1
5

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 100 publications
0
3
0
Order By: Relevance
“…rs10488763 is also not associated with non-cardiovascular diseases in these datasets. There was also little evidence for association of rs10488763 with nuclear magnetic resonance (NMR) spectroscopy-based serum metabolomic profile in 12,120 Asian and 456,571 European participants from the UK Biobank study 26 ( Supplementary Table 10 ). Genetic variants in FDX1 thus appear to have a specific effect on cardiovascular disease, that is independent of, and not mediated by, traditional risk factors.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…rs10488763 is also not associated with non-cardiovascular diseases in these datasets. There was also little evidence for association of rs10488763 with nuclear magnetic resonance (NMR) spectroscopy-based serum metabolomic profile in 12,120 Asian and 456,571 European participants from the UK Biobank study 26 ( Supplementary Table 10 ). Genetic variants in FDX1 thus appear to have a specific effect on cardiovascular disease, that is independent of, and not mediated by, traditional risk factors.…”
Section: Resultsmentioning
confidence: 99%
“…We tested association of 168 NMR-based metabolite biomarkers with the candidate SNP, rs10488763, in the full UK Biobank within principal component-assigned ancestry groups 26 . Biomarker values were log(1 + x) transformed, and values more than 4 standard deviations from the mean were removed.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Conflicting conclusions exist for other metabolites, and little is known about the role of genetics in mediating these relationships. The genetic regulation of metabolite profiles is increasingly described, for example through the latest meta-analysis reporting over 400 independent loci associated with 233 metabolite levels 19 . These metabolite QTLs, also called mQTLs, are usually reported in the general population, and studies are starting to emerge on how they are modified by factors such as diet 20 .…”
Section: Introductionmentioning
confidence: 99%
“…Metabolomics emerges as an enabling technique to identify circulating metabolites as potential disease biomarkers, including cardiovascular diseases (CVD). 1 Although dysregulation of lipid metabolism has been implicated in CVD, yet a comprehensive analysis of their underlying metabolomic profiles and disease‐specific metabolic biomarkers is lacking, especially for polar metabolites. 2 In a large cohort of 10741samples, Zeller et al.…”
mentioning
confidence: 99%